Endoscopic Innovation Treatment Strategy in Hepatocellular Carcinoma ( <scp>HCC</scp> ) Patients Before Immunotherapy: A Case Series Study in Unselected Patients

Key Takeaways for GI Nurses

• Endoscopic interventions are being explored as preparatory treatments to optimize hepatocellular carcinoma (HCC) patients before immunotherapy initiation, representing an evolving multimodal approach to cancer care
• This case series methodology suggests that endoscopic treatments may play a strategic role in conditioning HCC patients for subsequent systemic therapy, requiring enhanced coordination between endoscopy and oncology services
• Unselected patient populations in HCC research indicate the need for comprehensive assessment skills, as nurses will encounter diverse disease presentations and varying baseline patient conditions
• The integration of endoscopic procedures into pre-immunotherapy protocols may influence patient preparation workflows, monitoring requirements, and interdisciplinary communication patterns

Clinical Relevance

This research highlights the expanding role of endoscopic interventions in the comprehensive management of HCC patients, particularly as bridge or preparatory treatments before immunotherapy. For endoscopy nurses, this represents a paradigm shift toward more complex, multi-phase treatment pathways that require sophisticated care coordination. Understanding the rationale behind pre-immunotherapy endoscopic interventions will be essential for patient education, as families often struggle to comprehend why multiple procedures are necessary before systemic treatment begins. Nurses must be prepared to explain how endoscopic treatments can optimize tumor burden, improve hepatic function, or address specific anatomical considerations that enhance immunotherapy effectiveness.

The case series approach using unselected patients particularly impacts nursing practice by emphasizing the importance of individualized assessment and care planning. Unlike highly controlled clinical trials with strict inclusion criteria, real-world HCC patients present with varying degrees of liver dysfunction, comorbidities, and performance status. This diversity demands enhanced clinical judgment skills from endoscopy nurses in recognizing subtle changes in patient condition, anticipating complications, and adapting standard protocols to accommodate individual patient needs. The integration of endoscopic procedures into pre-immunotherapy protocols also necessitates closer collaboration with oncology nursing colleagues, requiring clear communication channels and shared understanding of treatment goals and timelines.

From an operational perspective, this treatment strategy may influence unit scheduling, resource allocation, and staff competency requirements. Endoscopy units may need to accommodate more complex cases with longer procedure times, enhanced monitoring requirements, and potentially modified recovery protocols. Staff education programs should incorporate knowledge about immunotherapy mechanisms, potential interactions between endoscopic interventions and subsequent systemic treatments, and recognition of immune-related adverse events that may manifest during or after endoscopic procedures.

Bottom Line

The emergence of endoscopic interventions as strategic preparatory treatments before HCC immunotherapy represents a significant evolution in cancer care that requires endoscopy nurses to expand their clinical knowledge base, enhance interdisciplinary collaboration skills, and adapt care protocols to support increasingly complex, multi-phase treatment pathways that bridge procedural and systemic cancer therapies.